SFY 2022 - 2023 Behavioral Health Expenditure Target (BHET) Report Summary HIV-SNP
| SFY 2022 - 2023 MC BHET Report Summary | ||||||
|---|---|---|---|---|---|---|
| HIV SNP line of business | ||||||
| Plan | BHET % | BHET Target Expense | BHET Experience | Remittance | MMs | |
| Amida Care Inc. | 90.60% | $16,214,195 | $14,689,644 | $875,983 | 72,866 | |
| MetroPlus Health Plan, Inc | 106.18% | $10,369,649 | $11,010,221 | $0 | 46,925 | |
| VNS (d/b/a VNSNY Choice) and Subsidiary | 78.37% | $7,760,657 | $6,082,005 | $1,368,225 | 33,201 | |
| Total | $34,344,500 | $31,781,870 | $2,244,209 | 152,992 | ||
NOTES:
BHET Target 96%
